LAS VEGAS — Because the effect of donor diabetes history on keratoplasty outcomes is unknown, there is a need for prospective studies to manage its impact, according to a presentation here. Jonathan Lass, MD, discussed the growing problem of the impact of donor diabetes on the future of the cornea donor pool and patients requiring keratoplasty at the American Academy of Ophthalmology annual meeting.
Ranibizumab Deemed Major Advance for Diabetic Retinopathy
Ranibizumab was noninferior to panretinal photocoagulation for visual acuity in patients with proliferative diabetic retinopathy, according to 2-year results of the Protocol S Study. Medscape Medical News
Contact lens wearers at greater risk for Acanthamoeba keratitis than non-lens wearers
LAS VEGAS — In patients who are diagnosed with Acanthamoeba keratitis, 85% to 100% are contact lens wearers and 33% are orthokeratology patients, according to a speaker here. “The rates of risk are the same or very similar for hard and soft contact lens wearers. Orthokeratology patients are especially high risk… luckily, if you are a noncontact lens wearer, the risk is fairly low,” Elmer Y. Tu, MD, said at Cornea Subspecialty Day preceding the American Academy of Ophthalmology annual meeting.
OASIS: Single Jetrea injection results in long-term resolution of vitreomacular adhesion
LAS VEGAS — A single intravitreal injection of 0.125 mg of ocriplasmin can result in long-term resolution of vitreomacular adhesion, according to a presentation here. At the American Academy of Ophthalmology annual meeting, Peter K. Kaiser, MD, presented results from the OASIS study evaluating a single injection of Jetrea (ocriplasmin, Thrombogenics) in patients with vitreomacular adhesion (VMA), including macular hole, and vitreomacular traction (VMT) at 24 months.
VIDEO: Surgeon presents new data on the Kamra inlay
LAS VEGAS — At the American Academy of Ophthalmology, Phillip C. Hoopes, MD, discusses 3-month data on the first 32 patients who were implanted with the Kamra inlay (Acufocus) at Hoopes Vision.
Speaker: Prevention key to managing neurotrophic keratopathy
LAS VEGAS — Prevention is key to managing varicella zoster virus neurotrophic keratopathy, according to a speaker here. “This is the diabetic foot ulcer of the eye,” Todd Margolis, MD, PhD, said at Cornea Subspecialty Day preceding the American Academy of Ophthalmology meeting. Neurotrophic keratopathy is characterized by decreased corneal sensation and poor corneal healing.